Summary
This study compared the survival of patients with glioblastoma (GBM) who participated in clinical trials to those who didn’t. It found that survival is extended for trial participants and encourages enrolment in clinical trials where this is possible. The article provides a lot of statistics on factors that impact survival such as age, co-morbidities, performance status, type of operation. Read the abstract as it is a good summary and beware of study limitations (see discussion). You can find out more about participating in trials here.
Full text
The full text is attached below.
Research publication
Field, K. M., Drummond, K. J., Yilmaz, M., Tacey, M., Compston, D., Gibbs, P., & Rosenthal, M. A. (2013). Clinical trial participation and outcome for patients with glioblastoma: multivariate analysis from a comprehensive dataset. J Clin Neurosci, 20(6), 783-789.